the present invention reveals a new use of neferine . neferine regulates m8 and v1 subtype of transient receptor potential ion channel , respectively , in mammalians , including humans , and can be used for preparing medicaments for treating disease related to said ion channel . the potency of neferine in the present invention is higher than that of hexahydrothymol .